The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to compare the therapy effects and clinical safety of a regulatory metabolic compound, coenzyme A (CoA) with a marketed drug, abiraterone, in Chinese patients with castration-resistant prostate cancer (CRPC) .
Epistemonikos ID: c37a99adb9263daef25ca795ffc83a21df8c81f2
First added on: May 08, 2024